SCHEMBL7877183

SCHEMBL7877183

Clc1cccc(-c2nc3c(o2)CCC(c2nccnc2[C@H]2CN2)C3)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.36
ADRA1A P35348 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
NPC1 O15118 2/20 0.34
TP53 P04637 2/20 0.34
TSHR P16473 2/20 0.34
RAB9A P51151 2/20 0.34
NOTUM Q6P988 2/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
PIM1 P11309 1/20 0.34
IKBKB O14920 1/20 0.33
PDE10A Q9Y233 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
FYN P06241 1/20 0.33
MITF O75030 1/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7881578 1.00 GPR119 (0.36) GPR119ADRA1ASMN1; SMN2NPC1TP53
SCHEMBL7877057 0.87 GPR119 (0.43) GPR119NPC1RAB9APDE10AHPGD
SCHEMBL505548 0.85 ALOX15 (0.45) SMN1; SMN2NPC1TP53TSHRRAB9A
SCHEMBL505401 0.81 GRM5 (0.44) SMN1; SMN2NPC1TP53TSHRRAB9A
SCHEMBL505085 0.80 GRM5 (0.38) ADRA1ASMN1; SMN2NPC1TP53TSHR
SCHEMBL505082 0.80 NPC1 (0.45) GPR119SMN1; SMN2NPC1TP53TSHR
SCHEMBL10250549 0.79 TP53 (0.45) GPR119ADRA1ASMN1; SMN2NPC1TP53
SCHEMBL505629 0.77 KDM4E (0.40) ADRA1ASMN1; SMN2NPC1TP53TSHR
SCHEMBL7883808 0.77 GPR119 (0.44) GPR119NPC1RAB9AHPGDMAPT
SCHEMBL7880996 0.76 RAB9A (0.43) GPR119ADRA1ASMN1; SMN2NPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010114971-A1 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SEPRACOR INC. (US) 2010-10-07 WO disclosed